Charts Week Month
Heat map Market Overview
Sentiment Sectors ETFs
Earnings News Earnings Movers The Drift Pivots
The Big Picture Breakouts Full Earnings News
Investor Services

Earnings are the driver of stock prices and the right earnings information can help longer-term investors significantly outperform the overall stock market.

The Whisper Report ® A look at upcoming earnings from both a top-down and bottom-up basis. Grades Stocks with A+ Earnings Whisper Grades Have Significantly Outperformed the Stock Market. Call Summaries Conference call summaries. AI Call Analysis AI Conference call analysis. Earnings Daily earnings results. Guidance Daily earnings guidance from companies. Reactions Earnings Screener Short Interest Report When the short trade becomes crowded.
Trader Service

Short-term earnings trading tools built around expectations, sentiment, quantitative studies, volatility, and post-earnings drift.

Trading Strategy The current strategy based on a broad market analysis and data. Earnings Whisper Plays Combining research, sentiment, quantitative studies, and technical analysis for short-term trades. Scores Identifying the likely Earnings Announcement Premium. Power Ratings Earnings with enough power for a short-term Post-Earnings Announcement Drift. Whisperings ^TM Whisperings are comments from analysts about upcoming earnings releases. AI Call Rankings Find which companies had the strongest or weakest conference calls. Option Trades Volatility Options Activity Unusual options activity around earnings. Setups Unusual options activity around earnings. Reversals Unusual options activity around earnings. Spikes Unusual options activity around earnings.
Dashboard

ABCL AbCellera Biologics Inc.

NASDAQ

$11.38

AbCellera Biologics Inc. (ABCL) Earnings News

Earnings press releases and Earnings Whispers previews for AbCellera Biologics Inc. (ABCL), newest first.

Wednesday August 5, 2026 4:05 PM ET

AbCellera Reports Q2 2026 Business Results

Thursday July 23, 2026 9:05 AM ET

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

Wednesday July 15, 2026 8:45 AM ET

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

Tuesday July 7, 2026 4:05 PM ET

AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

Monday May 11, 2026 4:05 PM ET

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

Monday April 20, 2026 9:00 AM ET

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Wednesday April 1, 2026 4:05 PM ET

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Tuesday February 24, 2026 4:05 PM ET

AbCellera Reports Full Year 2025 Business Results